apposters.com

Kimba Unveils AI Scent Therapy, Secures $6.5M to Transform Sleep Health

June 19, 2026, 9:48 am
Selva Ventures
BeautyConsumerSkincareProductPetFoodTechEnergyTechDTCEcommerceBiotech
Employees: 1-10
WHOOP
WHOOP
AIBiometricsFitnessHealthTechWearables
Location: United States
Employees: 501-1000
Founded date: 2012
Total raised: $976M
Fitbit
Fitbit
ActiveDataE-commerceFamilyFitnessHealthTechProductPublicSmartWearables
Location: United States, California, San Francisco
Employees: 1001-5000
Founded date: 2007
Garmin
ConsumerElectronicsFitnessGPSTechWearables
Location: United States
Employees: 10001+
Founded date: 1989
Kimba has officially launched its innovative AI-powered scent therapy platform, securing a substantial $6.5 million in funding. This new sleep technology company aims to revolutionize rest. It leverages advanced biometric monitoring and artificial intelligence. The system builds personalized sleep profiles. It then delivers precisely timed, plant-derived scent formulations. These cues influence brain activity through the olfactory pathway. The goal is deeper, more restorative sleep, free from drugs or disruptions. Initial clinical studies confirm significant improvements in sleep quality and cognitive function. This funding fuels Kimba's commercial debut. It also supports its mission to establish a new category in active, personalized sleep enhancement. The company moves beyond mere tracking. It offers a proactive solution for optimal sleep health.

A new era in sleep technology has begun. Kimba, a New York City-based innovator, recently announced its launch. The company simultaneously secured $6.5 million in funding. This investment propels its AI-powered scent therapy platform into the market. Selva Ventures led the significant funding round.

Kimba promises a groundbreaking approach to sleep improvement. It moves beyond passive sleep tracking. The system actively enhances sleep quality. This is achieved through personalized, adaptive scent interventions. The core mission is to deliver deeper, more restorative rest. This comes without drugs or unwanted interruptions.

Ben Fuxbruner founded Kimba. He previously served as a special forces commander. His inspiration stemmed from personal struggles. Fuxbruner experienced PTSD and chronic insomnia. These issues followed a near-fatal injury. He sought a life-changing solution for better sleep. Kimba is that solution.

The technology behind Kimba is sophisticated. It constructs a unique sleep profile for each user. This profile guides the therapy. Proprietary scent formulations are at its heart. These are water-based and plant-derived. They are tailored to individual sleep patterns. Preferences are also factored into the formulation.

Kimba continuously monitors vital biometric signals. Built-in sensors capture crucial data. This includes breathing patterns, movement, and heart rate variability. Stress indicators are also tracked. The system integrates seamlessly with popular wearables. WHOOP, Oura, Apple Watch, Fitbit, and Garmin are all compatible.

An adaptive AI engine processes this information. It analyzes data in real time. The AI understands the body's changing sleep state. It then precisely delivers timed scent cues. These interventions optimize sleep depth. They also enhance continuity and recovery. The focus is on truly effective rest.

The olfactory pathway plays a critical role. This sensory channel can influence the brain. It works effectively during sleep. Crucially, it does so without causing wakefulness. Kimba utilizes this unique capability. It offers personalized olfactory interventions. This supports restorative sleep naturally.

Clinical validation supports Kimba’s claims. Early studies involved 50 participants. They spanned 48 nights. Results demonstrated significant improvements in sleep quality. Participants also experienced better cognitive performance. Dr. Anat Arzi, an expert in olfactory neuroscience, contributed to this research.

Further clinical studies are underway. Professor Peretz Lavie, a renowned sleep expert, guides these efforts. The research focuses on physiological sleep outcomes. It also explores the technology's effects on PTSD. Mental health recovery is another key area of investigation. This expands Kimba's potential impact.

Selva Ventures’ investment underscores confidence in Kimba. Their portfolio includes other health and wellness brands. Grüns and OneSkin are notable examples. This funding specifically supports Kimba's commercial launch. It also accelerates efforts to establish a new market category. This category focuses on active, personalized sleep enhancement.

Kimba represents a shift in the sleep industry. It transitions from passive measurement to active intervention. Consumers no longer just track sleep. They can now proactively improve it. This offers a powerful solution for millions suffering from poor sleep. It addresses a critical, underserved health pillar.

The Kimba system is now available for pre-order. The package is comprehensive. It includes the device itself. Software access is also part of the offering. A six-month membership provides ongoing support. Furthermore, a six-month supply of personalized scents is included. The entire package is priced at $299.

This innovative sleep device targets a broad audience. It appeals to those seeking natural sleep solutions. Individuals with chronic insomnia may benefit. Veterans struggling with PTSD could find relief. Anyone aiming for enhanced cognitive performance will also see value. Kimba offers a non-pharmacological path to better health.

The company's launch marks a pivotal moment. Sleep health is gaining increased attention. Personalized wellness solutions are highly sought after. Kimba aligns perfectly with these trends. Its AI-driven scent therapy stands ready to redefine nightly routines. It offers a tangible promise of deeper, more rejuvenating sleep for all.